Best Weight Loss Program Near Me: How to Compare Your Options

The best weight loss program near you is one that is medically appropriate, sustainable, clear about cost, and built for follow-up—not just a short diet. Look for licensed clinician review, nutrition and behavior guidance, safety screening, and clear rules for any prescription medication, including GLP-1 treatment.

How did we evaluate the best weight loss programs?

We ranked program types by five practical factors: medical safety, evidence for long-term weight management, access to follow-up, cost clarity, and whether prescription medication is handled through licensed clinical review. Weight loss programs vary widely, so the right choice depends on your health history and how much support you need.

• Safety: licensed clinician oversight, review of medications and health history, and a plan for side effects.
• Evidence: support for nutrition, physical activity, behavior change, and chronic weight management. The USPSTF recommends intensive, multicomponent behavioral interventions for adults with obesity 1.
• Medication process: clear eligibility screening before GLP-1 receptor agonist or GIP/GLP-1 receptor agonist prescribing.
• Access: follow-up visits, portal messaging, or local visits when needed.
• Cost: monthly price, medication cost, labs, food, coaching, and cancellation terms.

1. Best for safety: programs with licensed clinician oversight

If a program includes prescription medication, licensed clinical oversight is the first filter. Medical weight loss should include review of BMI, weight history, current medications, pregnancy status, and conditions such as type 2 diabetes, prediabetes, hypertension, high cholesterol, kidney disease, gallbladder disease, pancreatitis history, and metabolic syndrome.

• Best for: people with obesity, overweight plus metabolic risk, complex medication lists, or prior side effects from weight loss treatment.
• Key features: health history review, medication screening, side-effect education, and follow-up.
• What works: obesity guidelines support long-term care that combines lifestyle treatment, medical risk review, and, for eligible patients, anti-obesity medication 2.
• Limitations: medical programs can cost more than coaching-only plans, and prescriptions are not appropriate for everyone.

For GLP-1 medications, safety review matters because side effects can include nausea, vomiting, diarrhea, constipation, abdominal pain, and reduced appetite. FDA labels for semaglutide and tirzepatide also include warnings and precautions related to pancreatitis, gallbladder disease, kidney injury from dehydration, pregnancy, and thyroid C-cell tumor risk warnings for people with a personal or family history of medullary thyroid carcinoma or MEN2 3 4.

2. Best for long-term results: programs that combine nutrition, behavior change, and follow-up

For lasting change, a program should not rely on willpower alone. Long-term weight management works best when it helps you build a calorie deficit, improve food quality, add physical activity, and handle real-life triggers.

• Best for: people who want structure without starting with medication.
• Key features: nutrition counseling, physical activity guidance, sleep and stress support, and accountability.
• What works: the Diabetes Prevention Program showed that intensive lifestyle intervention reduced progression to type 2 diabetes in high-risk adults, with long-term follow-up showing durable benefit 5.
• Limitations: coaching-only programs may not be enough for people whose appetite regulation, satiety, medications, or metabolic risk make weight loss harder.

A good plan is flexible. It should teach repeatable habits, not extreme rules. Programs built around very low calories, rigid food lists, or rapid deadlines may be hard to sustain and may not be safe for people with certain medical conditions.

3. Best for medication support: programs that screen eligibility before prescribing

Medication can be helpful for some adults, but it should sit inside a broader plan. GLP-1 receptor agonist drugs such as Wegovy (semaglutide) and related compounded semaglutide via state-licensed 503A pharmacy pathways affect appetite regulation and satiety; GIP/GLP-1 receptor agonist drugs such as Zepbound (tirzepatide) and related compounded tirzepatide pathways act on both GIP and GLP-1 receptors 3 4.

• Best for: adults who may meet criteria for chronic weight management medication after clinician review.
• Key features: eligibility screening, contraindication review, side-effect monitoring, and dose adjustments by a clinician.
• What works: in STEP 1, adults without diabetes receiving semaglutide 2.4 mg once weekly plus lifestyle intervention lost more weight than those receiving placebo plus lifestyle intervention; individual results varied 6.
• What works: in SURMOUNT-1, adults with obesity or overweight without diabetes receiving tirzepatide once weekly had greater weight reduction than placebo; individual results varied 7.
• Limitations: these trial results apply to the studied active ingredients and FDA-approved trial products, not to compounded formulations. Compounded formulations are not FDA-approved and do not have FDA-evaluated outcomes data.

Medication benefits and risks should be discussed together. Nausea, vomiting, diarrhea, constipation, abdominal pain, and reduced appetite are common enough that a program should explain what to do if they happen. A clinician should also review pregnancy, pancreatitis history, gallbladder disease, kidney disease, and the medullary thyroid carcinoma or MEN2 warning before prescribing 3 4.

4. Best for convenience: telehealth medical weight loss with real provider review

Telehealth can be a good fit when you want medical review without repeated clinic visits. Telehealth medical weight loss is strongest when it includes licensed provider evaluation, secure messaging, pharmacy sourcing transparency, and follow-up—not just an online checkout.

• Best for: busy adults who want online care and home delivery where appropriate.
• Key features: online questionnaire, clinician review, portal messaging, and provider-guided changes over time.
• What works: remote care can support chronic disease management when programs maintain clinician access, medication review, and follow-up workflows 8.
• Limitations: telehealth may not fit people who need hands-on exams, local lab coordination, urgent evaluation, or intensive in-person support.

The safety line is not “online versus local.” It is licensed versus unlicensed. A legitimate online program should use licensed clinicians and state-licensed pharmacy partners, not no-prescription sellers or “research chemical” vendors.

5. Best for local support: in-person or hybrid programs

Some people do better with face-to-face visits. In-person clinics may be a good fit if you need physical exams, local lab support, supervised activity, eating-disorder screening, or close monitoring for complex conditions.

• Best for: people who want regular visits, body-composition checks, or local care coordination.
• Key features: clinic visits, labs, nutrition visits, and sometimes medication management.
• What works: structured programs can help patients stay engaged, especially when follow-up is frequent and goals are realistic 1.
• Limitations: visit schedules, travel time, and unclear add-on fees can make some local programs hard to maintain.

Hybrid programs can work well if you want periodic in-person care plus online check-ins. If medication is involved, the same rules apply: prescriptions should follow a clinical review, side effects should be explained, and costs should be transparent.

How do popular weight loss program types compare?

The best choice depends on the kind of support you need. Program types differ most in clinical oversight, cost, convenience, and whether they can safely evaluate prescription medication.

Weight loss treatment at Chia: online GLP-1 care with provider review

At Chia, our weight loss care is 100% online. Chia GLP-1 care starts with a short health questionnaire, then a licensed US provider reviews your information and prescribes only when clinically appropriate.

We offer compounded tirzepatide as tablets or injections, with plans currently starting at $249/month for tablets and $299/month for injections. We also offer compounded semaglutide injections, with plans currently starting at $249/month. Microdosing plans are available for tirzepatide and semaglutide when a provider determines that approach fits the patient.

Chia medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to the patient’s door. Patients can message their care team through the portal between visits, and dosing is guided and adjusted by the provider over time.

Some patients ask about pairing weight care with energy or body-composition support. Chia offers Weight + Energy, which includes NAD+ injection plus a choice of GLP-1, and Weight + Muscle, which includes sermorelin injection plus a choice of GLP-1, when clinically appropriate.

How much do weight loss programs usually cost?

Costs vary because programs bundle different things. Monthly cost may include coaching, visits, labs, food, medication, shipping, membership fees, or follow-up support.

• Coaching-only programs may charge a membership fee but may not include medical review.
• Meal-based programs may advertise a low plan price while food is separate.
• Medical clinics may bill visits, labs, body-composition scans, and medications separately.
• Telehealth programs may bundle provider review, medication management, pharmacy coordination, and shipping.
• Very low advertised prices may not include medication, refills, follow-up, or cancellation fees.

To compare fairly, ask for the expected monthly total, not just the sign-up price. For Chia’s GLP-1 options, plans currently start at $249/month for tirzepatide tablets, $299/month for tirzepatide injections, and $249/month for semaglutide injections; product pages show current pricing.

How can you check whether a program near you is legitimate?

A legitimate program should be easy to verify. Licensed oversight and transparent medication sourcing are the most important safety signals.

1. 1Confirm who reviews your health history and whether that person is licensed to prescribe in your state.
2. 2Ask whether prescriptions are based on eligibility review or guaranteed. Guaranteed prescriptions are a red flag.
3. 3Ask where compounded medications come from. A safer medical path uses state-licensed 503A compounding pharmacies, not no-prescription vendors.
4. 4Look for clear side-effect education, including nausea, vomiting, diarrhea, constipation, abdominal pain, dehydration risk, gallbladder symptoms, and when to seek urgent care.
5. 5Avoid programs promising rapid, guaranteed, or effortless weight loss. Obesity is a chronic disease, and chronic weight management usually needs ongoing support 2.

FDA-approved brand medications such as Wegovy (semaglutide), Ozempic (semaglutide for type 2 diabetes), Zepbound (tirzepatide), and Mounjaro (tirzepatide for type 2 diabetes) have FDA-reviewed labeling for their approved uses 3 4. Compounded semaglutide via 503A pharmacy and compounded tirzepatide via 503A pharmacy are different regulatory pathways and should be discussed with a licensed clinician.

What questions should you ask before joining a weight loss program?

The right questions can reveal whether a program is built for safety or just sales. Before you sign up, ask about medical review, follow-up, pricing, and what happens if treatment needs to change.

• Who reviews my health history, BMI, medications, and metabolic risk?
• What happens if I have nausea, vomiting, constipation, abdominal pain, or other side effects?
• How often can my plan be adjusted, and can I message the care team?
• What is included in the monthly price, and what is billed separately?
• Are labs required for my situation, and who reviews them?
• What happens when I reach my goal weight or if I stop medication?
• Where are compounded medications made, and are they dispensed by a state-licensed 503A pharmacy?
• Is prescription medication based on eligibility review, or is it being promised upfront?

Where do GLP-1 medications fit into a weight loss program?

GLP-1 medications are not a stand-alone plan. Semaglutide and tirzepatide can support appetite regulation and satiety in eligible adults, but they work best inside a program that also supports nutrition, activity, follow-up, and side-effect management.

The FDA-approved starting dose for Wegovy is 0.25 mg once weekly for the first 4 weeks, with stepwise titration to a maintenance dose listed in the label; this is label information, not individual dosing advice 3. The FDA-approved Zepbound label lists a 2.5 mg once-weekly starting dose for 4 weeks followed by escalation based on the labeled schedule; this is also label information, not a personal instruction 4.

In clinical trials, the active ingredients semaglutide and tirzepatide produced meaningful average weight loss compared with placebo when paired with lifestyle intervention, but individual results varied 6 7. Programs should discuss benefits in the same visit as risks, including gastrointestinal side effects, dehydration, gallbladder symptoms, pancreatitis warnings, pregnancy considerations, and the medullary thyroid carcinoma or MEN2 warning 3 4.

Keep reading

Metabolic Health

Metabolic Syndrome and Weight Loss: What the Evidence Shows

Weight Loss Medication

Metformin Dose for Weight Loss: What the Evidence Actually Shows

Weight Loss

2-Month Metformin Weight Loss Results: What to Realistically Expect